Researchers compared ribociclib 400 mg with ribociclib 600 mg plus a nonsteroidal aromatase inhibitor in patients with hormone receptor-positive/ERBB2-negative advanced breast cancer.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/lower-dose-ribociclib-equally-effective-breast-cancer-2025a1000pnx?src=rss
Author :
Publish date : 2025-09-25 15:05:00
Copyright for syndicated content belongs to the linked Source.